A serum miRNAs signature for early diagnosis of bladder cancer

BACKGROUND: Bladder cancer accounts for the most common type of urologic malignancy and presents high recurrence rate after surgical resection and adjuvant intravesical therapy. We aim to search for an early diagnostic biomarker in serum for bladder cancer in this study. METHODS: The expression prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Zuhu, Lu, Chong, Lai, Yongqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980012/
https://www.ncbi.nlm.nih.gov/pubmed/36856518
http://dx.doi.org/10.1080/07853890.2023.2172206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980012/
https://www.ncbi.nlm.nih.gov/pubmed/36856518
http://dx.doi.org/10.1080/07853890.2023.2172206

Ejemplares similares